Vasopressin Mechanism: V1a, V2, Pressure and Flow
How do vasopressin V1a and V2 receptors produce different effects?
Vasopressin acts through different receptors in different tissues. V1a signaling promotes vascular smooth-muscle contraction, while V2 signaling increases collecting-duct water permeability. An arterial pressure rise from increased vascular resistance does not automatically mean cardiac output or regional tissue perfusion increased.
Key takeaways
- V1a and V2 are different receptor and tissue pathways.
- Aquaporin insertion changes water permeability; it does not actively pump water.
- Nonadrenergic action does not mean the heart or clinical context no longer matters.
In this video
- Pressure still will not hold
- Endogenous hormone and exogenous drug
- Approved use and adult septic shock
- V1a Gq PLC and stored calcium
- Calmodulin MLCK and contraction
- V2 and collecting-duct water response
- Tubule permeability is not renal perfusion
- Pressure versus cardiac output
- Venous tone and return
- The pressure-flow model
- Heart effects and whole response
- Acidosis evidence limits
- CRNA interview reasoning
- Practice questions
- Recap
How does V1a signaling change vascular tone?
V1a receptors in vascular smooth muscle signal through Gq, phospholipase C and IP3. Release of stored calcium supports calmodulin and myosin light-chain kinase activity, allowing contraction. That chain explains how a receptor signal changes vessel tone.
It does not establish that all vascular beds respond identically or that increased pressure guarantees better regional flow. Ischemic and cardiac effects remain relevant to the clinical response.
How does V2 signaling change water handling?
In collecting-duct cells, V2 signaling through Gs, adenylyl cyclase, cyclic AMP and protein kinase A promotes insertion of aquaporin-2 channels into the apical membrane. The membrane becomes more permeable to water.
Water movement still depends on the surrounding osmotic gradient. The receptor does not actively pump water across the membrane. The tissue and downstream signaling explain why this effect differs from vascular smooth-muscle contraction.
Why can pressure and flow move differently?
Higher systemic vascular resistance can increase pressure while cardiac output stays unchanged or falls. A pressure response therefore needs interpretation alongside perfusion, rhythm and the circulation’s other determinants.
Vasopressin does not require beta-1 receptor stimulation for its vascular action. That does not imply no cardiac effects, guaranteed response during acidosis or a proven renal-protection benefit. This explanation does not prescribe an infusion dose or claim that one pressure change establishes recovery.
